Perturbed length-dependent activation in human hypertrophic cardiomyopathy with missense sarcomeric gene mutations

Circulation Research

Volumn 112, Issue 11, 2013, Pages 1491-1505

  Sequeira, Vasco ^a   Wijnker, Paul J M ^a   Nijenkamp, Louise L A M ^a   Kuster, Diederik W D ^a,c   Najafi, Aref ^a   Witjas Paalberends, E Rosalie ^a   Regan, Jessica A ^a,b   Boontje, Nicky ^a   Ten Cate, Folkert J ^e   Germans, Tjeerd ^b   Carrier, Lucie ^f,g,h   Sadayappan, Sakthivel ^b   Van Slegtenhorst, Marjon A ^d   Zaremba, Ruud ^a   Foster, D Brian ⁱ   Murphy, Anne M ^o   Poggesi, Corrado ^j   Dos Remedios, Cris ^k   Stienen, Ger J M ^a,l   Ho, Carolyn Y ^m   Michels, Michelle ^d   Van Der Velden, Jolanda ^a,n   more..

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^f DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^g SORBONNE UNIVERSITÉ   (France)

^h Sorbonne Université   (France)

ⁱ JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF FLORENCE   (Italy)

^k UNIVERSITY OF SYDNEY   (Australia)

^l VU UNIVERSITY AMSTERDAM   (Netherlands)

^m BRIGHAM AND WOMEN S HOSPITAL   (United States)

ⁿ ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^o NONE

more..

Author keywords

calcium; cardiomyopathy; contractility; hypertrophy; myocardium

Indexed keywords

ACTIN BINDING PROTEIN; ALPHA TROPOMYOSIN; CALCIUM ION; CYCLIC AMP DEPENDENT PROTEIN KINASE; MYOSIN BINDING PROTEIN C; MYOSIN HEAVY CHAIN; TROPONIN; TROPONIN I; TROPONIN T;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART MUSCLE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTROPHIC CARDIOMYOPATHY; MALE; MISSENSE MUTATION; MUSCLE LENGTH; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SARCOMERE; SARCOMERE LENGTH; THIN FILAMENT;

CALCIUM; CARDIOMYOPATHY; CONTRACTILITY; HYPERTROPHY; MYOCARDIUM;

ADOLESCENT; ADULT; AGED; ANIMALS; CALCIUM; CARDIAC MYOSINS; CARDIOMYOPATHY, HYPERTROPHIC; CARRIER PROTEINS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; FEMALE; HUMANS; ISOMETRIC CONTRACTION; MALE; MAP KINASE KINASE KINASES; MICE; MIDDLE AGED; MUTATION, MISSENSE; MYOCARDIAL CONTRACTION; MYOCARDIUM; MYOFIBRILS; MYOSIN HEAVY CHAINS; PHOSPHORYLATION; SARCOMERES; TROPOMYOSIN; TROPONIN T; YOUNG ADULT;

EID: 84878624242     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.111.300436     Document Type: Article

References (72)

1. de Tombe PP, Mateja RD, Tachampa K, Ait Mou Y, Farman GP, Irving TC. Myofilament length dependent activation. J Mol Cell Cardiol. 2010;48:851-858.
2. Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE. Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA study. Circulation. 1995;92:785-789.
3. Tardiff JC. Sarcomeric proteins and familial hypertrophic cardiomyopathy: linking mutations in structural proteins to complex cardiovascular phenotypes. Heart Fail Rev. 2005;10:237-248.
4. Richard P, Charron P, Carrier L, et al; EUROGENE Heart Failure Project. Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation. 2003;107:2227-2232.
5. Santos S, Marques V, Pires M, Silveira L, Oliveira H, Lança V, Brito D, Madeira H, Esteves JF, Freitas A, Carreira IM, Gaspar IM, Monteiro C, Fernandes AR. High resolution melting: improvements in the genetic diagnosis of hypertrophic cardiomyopathy in a Portuguese cohort. BMC Med Genet. 2012;13:17.
6. Nagueh SF, Kopelen HA, Lim DS, Zoghbi WA, Quiñones MA, Roberts R, Marian AJ. Tissue Doppler imaging consistently detects myocardial contraction and relaxation abnormalities, irrespective of cardiac hypertrophy, in a transgenic rabbit model of human hypertrophic cardiomyopathy. Circulation. 2000;102:1346-1350.
7. + sensitivity and diastolic dysfunction as early consequences of Mybpc3 mutation in heterozygous knock-in mice. J Mol Cell Cardiol. 2012;52:1299-1307.
8. Nagueh SF, Bachinski LL, Meyer D, Hill R, Zoghbi WA, Tam JW, Quiñones MA, Roberts R, Marian AJ. Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy. Circulation. 2001;104:128-130.
9. Ho CY, Carlsen C, Thune JJ, Havndrup O, Bundgaard H, Farrohi F, Rivero J, Cirino AL, Andersen PS, Christiansen M, Maron BJ, Orav EJ, Køber L. Echocardiographic strain imaging to assess early and late consequences of sarcomere mutations in hypertrophic cardiomyopathy. Circ Cardiovasc Genet. 2009;2:314-321.
10. Germans T RI, Götte MJ, Spreeuwenberg MD, Doevendans PA, Pinto YM, van der Geest RJ, van der Velden J, Wilde AA, van Rossum AC. How do hypertrophic cardiomyopathy mutations affect myocardial function in carriers with normal wall thickness? Assessment with cardiovascular magnetic resonance. J Cardiovas Mag Res. 2010;12:13.
11. Watkins H, McKenna WJ, Thierfelder L, Suk HJ, Anan R, O'Donoghue A, Spirito P, Matsumori A, Moravec CS, Seidman JG, Seidman CE. Mutations in the genes for cardiac troponin T and α-tropomyosin in hypertrophic cardiomyopathy. New Eng J Med. 1995;332:1058-1065.
12. +-dependent action potential remodeling. Circ Res. 2003;92:428-436.
13. Schober T, Huke S, Venkataraman R, Gryshchenko O, Kryshtal D, Hwang HS, Baudenbacher FJ, Knollmann BC. Myofilament Ca sensitization increases cytosolic Ca binding affinity, alters intracellular Ca homeostasis, and causes pause-dependent Ca-triggered arrhythmia. Circ Res. 2012;111:170-179.
14. Hoskins AC, Jacques A, Bardswell SC, McKenna WJ, Tsang V, dos Remedios CG, Ehler E, Adams K, Jalilzadeh S, Avkiran M, Watkins H, Redwood C, Marston SB, Kentish JC. Normal passive viscoelasticity but abnormal myofibrillar force generation in human hypertrophic cardiomyopathy. J Mol Cell Cardiol. 2010;49:737-745.
15. van Dijk SJ, Paalberends ER, Najafi A, Michels M, Sadayappan S, Carrier L, Boontje NM, Kuster DW, van Slegtenhorst M, Dooijes D, dos Remedios C, ten Cate FJ, Stienen GJ, van der Velden J. Contractile dysfunction irrespective of the mutant protein in human hypertrophic cardiomyopathy with normal systolic function. Circ Heart Fail. 2012;5:36-46.
16. van Dijk SJ, Dooijes D, dos Remedios C, Michels M, Lamers JM, Winegrad S, Schlossarek S, Carrier L, ten Cate FJ, Stienen GJ, van der Velden J. Cardiac myosin-binding protein C mutations and hypertrophic cardiomyopathy: haploinsufficiency, deranged phosphorylation, and cardiomyocyte dysfunction. Circulation. 2009;119:1473-1483.
17. + binding to cardiac troponin C. Am J Physiol. 1987;253:C90-C96.
18. Wannenburg T, Heijne GH, Geerdink JH, Van Den Dool HW, Janssen PM, De Tombe PP. Cross-bridge kinetics in rat myocardium: effect of sarcomere length and calcium activation. Am J Physiol Heart Circ Physiol. 2000;279:H779-H790.
19. Zaremba R, Merkus D, Hamdani N, Lamers JM, Paulus WJ, dos Remedios C, Duncker DJ, Stienen GJ, van der Velden J. Quantitative analysis of myofilament protein phosphorylation in small cardiac biopsies. Proteomics Clin Appl. 2007;1:1285-1290.
20. Hamdani N, Borbély A, Veenstra SP, Kooij V, Vrydag W, Zaremba R, Dos Remedios C, Niessen HW, Michel MC, Paulus WJ, Stienen GJ, van der Velden J. More severe cellular phenotype in human idiopathic dilated cardiomyopathy compared to ischemic heart disease. J Muscle Res Cell Motil. 2010;31:289-301.
21. Wijnker PJM, Foster DB, Tsao AL, Frazier AH, dos Remedios C, Murphy AM, Stienen GJM, van der Velden J. Impact of site-specific phosphorylation of the protein kinase A sites ser23 and ser24 of cardiac troponin I in human cardiomyocytes. Am J Physiol. 2013;304:H260-H268.
22. Allen DG, Kentish JC. The cellular basis of the length-tension relation in cardiac muscle. J Mol Cell Cardiol. 1985;17:821-840.
23. Komukai K, Kurihara S. Length dependence of Ca(2+)-tension relationship in aequorin-injected ferret papillary muscles. Am J Physiol. 1997;273:H1068-H1074.
24. Konhilas JP, Irving TC, Wolska BM, Jweied EE, Martin AF, Solaro RJ, de Tombe PP. Troponin I in the murine myocardium: influence on length-dependent activation and interfilament spacing. J Physiol (Lond). 2003;547:951-961.
25. Tardiff JC. Thin filament mutations: developing an integrative approach to a complex disorder. Circ Res. 2011;108:765-782.
26. Freeman K, Colon-Rivera C, Olsson MC, Moore RL, Weinberger HD, Grupp IL, Vikstrom KL, Iaccarino G, Koch WJ, Leinwand LA. Progression from hypertrophic to dilated cardiomyopathy in mice that express a mutant myosin transgene. Am J Physiol Heart Circ Physiol. 2001;280:H151-H159.
27. Prabhakar R, Boivin GP, Grupp IL, Hoit B, Arteaga G, Solaro RJ, Wieczorek DF. A familial hypertrophic cardiomyopathy alpha-tropomyosin mutation causes severe cardiac hypertrophy and death in mice. J Mol Cell Cardiol. 2001;33:1815-1828.
28. Choudhury L, Guzzetti S, Lefroy DC, Nihoyannopoulos P, McKenna WJ, Oakley CM, Camici PG. Myocardial beta adrenoceptors and left ventricular function in hypertrophic cardiomyopathy. Heart. 1996;75:50-54.
29. Takahashi-Yanaga F, Morimoto S, Harada K, Minakami R, Shiraishi F, Ohta M, Lu QW, Sasaguri T, Ohtsuki I. Functional consequences of the mutations in human cardiac troponin I gene found in familial hypertrophic cardiomyopathy. J Mol Cell Cardiol. 2001;33:2095-2107.
30. Kobayashi T, Patrick SE, Kobayashi M. Ala scanning of the inhibitory region of cardiac troponin I. J Biol Chem. 2009;284:20052-20060.
31. Deng Y, Schmidtmann A, Redlich A, Westerdorf B, Jaquet K, Thieleczek R. Effects of phosphorylation and mutation R145G on human cardiac troponin I function. Biochemistry. 2001;40:14593-14602.
32. Davis J, Wen H, Edwards T, Metzger JM. Allele and species dependent contractile defects by restrictive and hypertrophic cardiomyopathylinked troponin I mutants. J Mol Cell Cardiol. 2008;44:891-904.
33. Kuster DW, Bawazeer AC, Zaremba R, Goebel M, Boontje NM, van der Velden J. Cardiac myosin binding protein C phosphorylation in cardiac disease. J Muscle Res Cell Motil. 2012;33:43-52.
34. Bardswell SC, Cuello F, Kentish JC, Avkiran M. cMyBP-C as a promiscuous substrate: phosphorylation by non-PKA kinases and its potential significance. J Muscle Res Cell Motil. 2012;33:53-60.
35. Haworth RS, Cuello F, Herron TJ, Franzen G, Kentish JC, Gautel M, Avkiran M. Protein kinase D is a novel mediator of cardiac troponin I phosphorylation and regulates myofilament function. Circ Res. 2004;95:1091-1099.
36. Kuster DW, Sequeira V, Najafi A, Boontje N, J.M. Wijnker PJM, Witjas- Paalberends ER, Marston S, dos Remedios CG, Carrier L, Demmers JA, Redwood CS, Sadayappan S, van der Velden J. GSK3β phosphorylates newly identified site in the Pro-Ala rich region of cardiac myosin binding protein C and alters cross-Bridge cycling kinetics in human. Circ Res. 2013;112:633-639.
37. Jideama NM, Noland TA Jr, Raynor RL, Blobe GC, Fabbro D, Kazanietz MG, Blumberg PM, Hannun YA, Kuo JF. Phosphorylation specificities of protein kinase C isozymes for bovine cardiac troponin I and troponin T and sites within these proteins and regulation of myofilament properties. J Biol Chem. 1996;271:23277-23283.
38. Stelzer JE, Patel JR, Moss RL. Protein kinase A-mediated acceleration of the stretch activation response in murine skinned myocardium is eliminated by ablation of cMyBP-C. Circ Res. 2006;99:884-890.
39. Chen PP, Patel JR, Rybakova IN, Walker JW, Moss RL. Protein kinase A-induced myofilament desensitization to Ca(2+) as a result of phosphorylation of cardiac myosin-binding protein C. J Gen Physiol. 2010;136:615-627.
40. Zhang P, Kirk JA, Ji W, dos Remedios CG, Kass DA, Van Eyk JE, Murphy AM. Multiple reaction monitoring to identify site-specific troponin I phosphorylated residues in the failing human heart. Circulation. 2012;126:1828-1837.
41. Avner BS, Shioura KM, Scruggs SB, Grachoff M, Geenen DL, Helseth DL Jr, Farjah M, Goldspink PH, Solaro RJ. Myocardial infarction in mice alters sarcomeric function via post-translational protein modification. Mol Cell Biochem. 2012;363:203-215.
42. Ramirez-Correa GA, Jin W, Wang Z, Zhong X, Gao WD, Dias WB, Vecoli C, Hart GW, Murphy AM. O-linked GlcNAc modification of cardiac myofilament proteins: a novel regulator of myocardial contractile function. Circ Res. 2008;103:1354-1358.
43. + binding and myofilament contractility. Physiol Genomics. 2008;33:257-266.
44. Cazorla O, Szilagyi S, Vignier N, Salazar G, Krämer E, Vassort G, Carrier L, Lacampagne A. Length and protein kinase A modulations of myocytes in cardiac myosin binding protein C-deficient mice. Cardiovasc Res. 2006;69:370-380.
45. + activation of myofilaments from transgenic mouse hearts expressing R92Q mutant cardiac troponin T. Am J Physiol. 2001;280:H705-H713.
46. Ford SJ, Mamidi R, Jimenez J, Tardiff JC, Chandra M. Effects of R92 mutations in mouse cardiac troponin T are influenced by changes in myosin heavy chain isoform. J Mol Cell Cardiol. 2012;53:542-551.
47. Arteaga GM, Palmiter KA, Leiden JM, Solaro RJ. Attenuation of length dependence of calcium activation in myofilaments of transgenic mouse hearts expressing slow skeletal troponin I. J Physiol (Lond). 2000;526(pt 3):541-549.
48. McKillop DF, Geeves MA. Regulation of the interaction between actin and myosin subfragment 1: evidence for three states of the thin filament. Biophys J. 1993;65:693-701.
49. Lehman W, Hatch V, Korman V, Rosol M, Thomas L, Maytum R, Geeves MA, Van Eyk JE, Tobacman LS, Craig R. Tropomyosin and actin isoforms modulate the localization of tropomyosin strands on actin filaments. J Mol Biol. 2000;302:593-606.
50. Vibert P, Craig R, Lehman W. Steric-model for activation of muscle thin filaments. J Mol Biol. 1997;266:8-14.
51. Pirani A, Xu C, Hatch V, Craig R, Tobacman LS, Lehman W. Single particle analysis of relaxed and activated muscle thin filaments. J Mol Biol. 2005;346:761-772.
52. Schaertl S, Lehrer SS, Geeves MA. Separation and characterization of the two functional regions of troponin involved in muscle thin filament regulation. Biochemistry. 1995;34:15890-15894.
53. Tobacman LS, Nihli M, Butters C, Heller M, Hatch V, Craig R, Lehman W, Homsher E. The troponin tail domain promotes a conformational state of the thin filament that suppresses myosin activity. J Biol Chem. 2002;277:27636-27642.
54. Gollapudi SK, Mamidi R, Mallampalli SL, Chandra M. The N-terminal extension of cardiac troponin T stabilizes the blocked state of cardiac thin filament. Biophys J. 2012;103:940-948.
55. Greenfield NJ, Huang YJ, Swapna GV, Bhattacharya A, Rapp B, Singh A, Montelione GT, Hitchcock-DeGregori SE. Solution NMR structure of the junction between tropomyosin molecules: implications for actin binding and regulation. J Mol Biol. 2006;364:80-96.
56. Murakami K, Stewart M, Nozawa K, Tomii K, Kudou N, Igarashi N, Shirakihara Y, Wakatsuki S, Yasunaga T, Wakabayashi T. Structural basis for tropomyosin overlap in thin (actin) filaments and the generation of a molecular swivel by troponin-T. Proc Natl Acad Sci USA. 2008;105:7200-7205.
57. Paul DM, Morris EP, Kensler RW, Squire JM. Structure and orientation of troponin in the thin filament. J Biol Chem. 2009;284: 15007-15015.
58. +-regulated muscle relaxation at interaction sites of troponin with actin and tropomyosin. J Mol Biol. 2005;352:178-201.
59. Takeda S, Yamashita A, Maeda K, Maéda Y. Structure of the core domain of human cardiac troponin in the Ca(2+)-saturated form. Nature. 2003;424:35-41.
60. Harvard Medical School Genetic database. Sarcomere protein gene mutation database. In: Cardiogenomics Harvard Medical School database. 2008. http://cardiogenomics.med.harvard.edu. Accessed April 5, 2013.
61. + affinity of cardiac thin filaments reconstituted with cardiomyopathy-related mutant cardiac troponin I. J Biol Chem. 2006;281:13471-13477.
62. El-Mezgueldi M, Wazeer Z. Transient kinetic analysis of hypertrophic and dilated cardiomyopathy linked mutations in troponin T. Abstract presented at: The 40th European Muscle Conference; Max-Delbrueck; Center for Molecular Medicine (MDC.C). Berlin, Germany on the 14th- 18th September 2011.
63. Burhop J, Rosol M, Craig R, Tobacman LS, Lehman W. Effects of a cardiomyopathy-causing troponin t mutation on thin filament function and structure. J Biol Chem. 2001;276:20788-20794.
64. Smith SH, Fuchs F. Effect of ionic strength on length-dependent Ca(2+) activation in skinned cardiac muscle. J Mol Cell Cardiol. 1999;31:2115-2125.
65. Head JG, Ritchie MD, Geeves MA. Characterization of the equilibrium between blocked and closed states of muscle thin filaments. Eur J Biochem. 1995;227:694-699.
66. Rao VS, Marongelli EN, Guilford WH. Phosphorylation of tropomyosin extends cooperative binding of myosin beyond a single regulatory unit. Cell Motil Cytoskeleton. 2009;66:10-23.
67. Pan BS, Gordon AM, Luo ZX. Removal of tropomyosin overlap modifies cooperative binding of myosin S-1 to reconstituted thin filaments of rabbit striated muscle. J Biol Chem. 1989;264:8495-8498.
68. Palm T, Greenfield NJ, Hitchcock-DeGregori SE. Tropomyosin ends determine the stability and functionality of overlap and troponin T complexes. Biophys J. 2003;84:3181-3189.
69. Rayment I, Holden HM, Sellers JR, Fananapazir L, Epstein ND. Structural interpretation of the mutations in the beta-cardiac myosin that have been implicated in familial hypertrophic cardiomyopathy. Proc Natl Acad Sci USA. 1995;92:3864-3868.
70. Farman GP, Gore D, Allen E, Schoenfelt K, Irving TC, de Tombe PP. Myosin head orientation: a structural determinant for the Frank- Starling relationship. Am J Physiol Heart Circ Physiol. 2011;300: H2155-H2160.
71. Mun JY, Gulick J, Robbins J, Woodhead J, Lehman W, Craig R. Electron microscopy and 3D reconstruction of F-actin decorated with cardiac myosin-binding protein C (cMyBP-C). J Mol Biol. 2011;410: 214-225.
72. Pak PH, Maughan WL, Baughman KL, Kieval RS, Kass DA. Mechanism of acute mechanical benefit from VDD pacing in hypertrophied heart: similarity of responses in hypertrophic cardiomyopathy and hypertensive heart disease. Circulation. 1998;98:242-248.